_id

690db068ccc777a4e85d0b7d

Ticker

ARCT

Name

Arcturus Therapeutics Holdings Inc

Exchange

NASDAQ

Address

10285 Science Center Drive, San Diego, CA, United States, 92121

Country

USA

Sector

Healthcare

Industry

Biotechnology

Currency

USD

Website

https://arcturusrx.com

Description

Arcturus Therapeutics Holdings Inc. engages in the development of infectious disease vaccines and other products within liver and respiratory rare diseases. Its technology platforms includes LUNAR lipid-mediated delivery and STARR mRNA. The company is developing ARCT-810 (LUNAR-OTC), a mRNA-based therapeutic candidate, which is in Phase 2 clinical trial for treating ornithine transcarbamylase deficiency; and ARCT-032 (LUNAR-CF), a mRNA therapeutic candidate that is in phase 2 clinical trial for cystic fibrosis. Its product pipeline includes KOSTAIVE for the treatment of covid 19; ARCT-2138 (LUNAR-FLU), which is in phase 1 clinical trial for the treatment of seasonal influenza; ARCT-2304 (LUNAR-H5N1) that is in phase 1 clinical trial for the treatment of Pandemic Influenza; ARCT-2301 for bivalent: ancestral/omicron which is in Phase 3 clinical trial; and ARCT-2303 for monovalent that is in Phase 3 clinical trial. Arcturus Therapeutics Holdings Inc. was founded in 2013 and is headquartered in San Diego, California.

Last Close

7.67

Volume

715544

Current Price

7.52

Change

-1.9556714471968755

Last Updated

2025-11-28T12:21:08.736Z

Image

data:image/webp;base64,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

Ipo Date

2020-04-16T00:00:00.000Z

Market Cap

193205248

Next Dividend Date

-

Dividend Frequency

-

Dividend Rate

-

Dividend Yield

0

Sentiment

0.9933333333333333

Sentiment Sources

3

Rating

4.7273

Target Price

35.5

Strong Buy

8

Buy

3

Hold

0

Sell

0

Strong Sell

0

Current Quarter

2025-09-30

Revenue

17151000

Cost Of Revenue

3342000

Gross Profit

13809000

Operating Expenses

30321000

Operating Income

-16512000

Interest Expense

-

Pretax Income

-13448000

Net Income

-13448000

Eps

-0.49462998381638956

Dividends Per Share

-

Shares Outstanding

28412537

Income Tax Expense

-16682000

EBITDA

-12685000

Operating Margin

-96.2742697218821

Total Other Income Expense Net

3064000

Cash

180360000

Short Term Investments

-

Receivables

7951000

Inventories

-

Total Current Assets

249200000

Property Plant Equipment

31258000

Total Assets

282343000

Payables

5491000

Short Term Debt

-

Long Term Debt

-

Total Liabilities

57784000

Equity

224559000

Depreciation

763000

Change In Working Capital

3666000

Cash From Operations

-17151000

Capital Expenditures

181000

Cash From Investing

-181000

Cash From Financing

1225000

Net Change In Cash

-16107000

PE

-

PB

0.9286288236053776

ROE

-5.988626597019047

ROA

-4.763001030661288

FCF

-17332000

Fcf Percent

-1.010553320506093

Piotroski FScore

0

Health Score

33

Deep Value Investing Score

6.5

Defensive Investing Score

7

Dividend Investing Score

1.5

Economic Moat Investing Score

5.3

Garp Investing Score

2.5

Growth Investing Score

1

Momentum Investing Score

3.5

Net Net Investing Score

4.5

Quality Investing Score

3

Value Investing Score

7

Quarters > 0 > quarter

2025-09-30

Quarters > 0 > income Statement > revenue

17151000

Quarters > 0 > income Statement > cost Of Revenue

3342000

Quarters > 0 > income Statement > gross Profit

13809000

Quarters > 0 > income Statement > operating Expenses

30321000

Quarters > 0 > income Statement > operating Income

-16512000

Quarters > 0 > income Statement > interest Expense

-

Quarters > 0 > income Statement > pretax Income

-13448000

Quarters > 0 > income Statement > net Income

-13448000

Quarters > 0 > income Statement > eps

-0.49462998381638956

Quarters > 0 > income Statement > dividends Per Share

-

Quarters > 0 > income Statement > shares Outstanding

27188000

Quarters > 0 > income Statement > income Tax Expense

-16682000

Quarters > 0 > income Statement > EBITDA

-12685000

Quarters > 0 > income Statement > operating Margin

-96.2742697218821

Quarters > 0 > income Statement > total Other Income Expense Net

3064000

Quarters > 0 > balance Sheet > cash

180360000

Quarters > 0 > balance Sheet > short Term Investments

-

Quarters > 0 > balance Sheet > receivables

7951000

Quarters > 0 > balance Sheet > inventories

-

Quarters > 0 > balance Sheet > total Current Assets

249200000

Quarters > 0 > balance Sheet > property Plant Equipment

31258000

Quarters > 0 > balance Sheet > total Assets

282343000

Quarters > 0 > balance Sheet > payables

5491000

Quarters > 0 > balance Sheet > short Term Debt

-

Quarters > 0 > balance Sheet > long Term Debt

-

Quarters > 0 > balance Sheet > total Liabilities

57784000

Quarters > 0 > balance Sheet > equity

224559000

Quarters > 0 > cash Flow > net Income

-13448000

Quarters > 0 > cash Flow > depreciation

763000

Quarters > 0 > cash Flow > change In Working Capital

3666000

Quarters > 0 > cash Flow > cash From Operations

-17151000

Quarters > 0 > cash Flow > capital Expenditures

181000

Quarters > 0 > cash Flow > cash From Investing

-181000

Quarters > 0 > cash Flow > cash From Financing

1225000

Quarters > 0 > cash Flow > net Change In Cash

-16107000

Quarters > 0 > ratios > PE

-0.49462998381638956

Quarters > 0 > ratios > PB

0.9286288236053776

Quarters > 0 > ratios > ROE

-5.988626597019047

Quarters > 0 > ratios > ROA

-4.763001030661288

Quarters > 0 > ratios > FCF

-17332000

Quarters > 0 > ratios > Piotroski FScore

0

Quarters > 0 > ratios > fcf Percent

-1.010553320506093

Quarters > 0 > health Score

33

Quarters > 1 > quarter

2025-06-30

Quarters > 1 > income Statement > revenue

24510000

Quarters > 1 > income Statement > cost Of Revenue

-

Quarters > 1 > income Statement > gross Profit

24510000

Quarters > 1 > income Statement > operating Expenses

36126000

Quarters > 1 > income Statement > operating Income

-11616000

Quarters > 1 > income Statement > interest Expense

-

Quarters > 1 > income Statement > pretax Income

-9176000

Quarters > 1 > income Statement > net Income

-9180000

Quarters > 1 > income Statement > eps

-0.3383832798849939

Quarters > 1 > income Statement > dividends Per Share

-

Quarters > 1 > income Statement > shares Outstanding

27129000

Quarters > 1 > income Statement > income Tax Expense

4000

Quarters > 1 > income Statement > EBITDA

-10837000

Quarters > 1 > income Statement > operating Margin

-47.39290085679315

Quarters > 1 > income Statement > total Other Income Expense Net

2440000

Quarters > 1 > balance Sheet > cash

196467000

Quarters > 1 > balance Sheet > short Term Investments

-

Quarters > 1 > balance Sheet > receivables

17204000

Quarters > 1 > balance Sheet > inventories

-

Quarters > 1 > balance Sheet > total Current Assets

274503000

Quarters > 1 > balance Sheet > property Plant Equipment

32881999

Quarters > 1 > balance Sheet > total Assets

309270000

Quarters > 1 > balance Sheet > payables

10623000

Quarters > 1 > balance Sheet > short Term Debt

4030999

Quarters > 1 > balance Sheet > long Term Debt

-

Quarters > 1 > balance Sheet > total Liabilities

78217000

Quarters > 1 > balance Sheet > equity

231053000

Quarters > 1 > cash Flow > net Income

-9180000

Quarters > 1 > cash Flow > depreciation

779000

Quarters > 1 > cash Flow > change In Working Capital

-5857000

Quarters > 1 > cash Flow > cash From Operations

-5755000

Quarters > 1 > cash Flow > capital Expenditures

0

Quarters > 1 > cash Flow > cash From Investing

-660

Quarters > 1 > cash Flow > cash From Financing

-14726000

Quarters > 1 > cash Flow > net Change In Cash

-20481000

Quarters > 1 > ratios > PE

-0.3383832798849939

Quarters > 1 > ratios > PB

0.9005701289314572

Quarters > 1 > ratios > ROE

-3.973114393667254

Quarters > 1 > ratios > ROA

-2.9682801435638764

Quarters > 1 > ratios > FCF

-5755000

Quarters > 1 > ratios > Piotroski FScore

1

Quarters > 1 > ratios > fcf Percent

-0.23480212158302732

Quarters > 1 > health Score

34

Quarters > 2 > quarter

2025-03-31

Quarters > 2 > income Statement > revenue

29382000

Quarters > 2 > income Statement > cost Of Revenue

-

Quarters > 2 > income Statement > gross Profit

29382000

Quarters > 2 > income Statement > operating Expenses

46208000

Quarters > 2 > income Statement > operating Income

-16826000

Quarters > 2 > income Statement > interest Expense

-

Quarters > 2 > income Statement > pretax Income

-14076000

Quarters > 2 > income Statement > net Income

-14076000

Quarters > 2 > income Statement > eps

-0.519275463902313

Quarters > 2 > income Statement > dividends Per Share

-

Quarters > 2 > income Statement > shares Outstanding

27107000

Quarters > 2 > income Statement > income Tax Expense

-16847000

Quarters > 2 > income Statement > EBITDA

-16025000

Quarters > 2 > income Statement > operating Margin

-57.26635354979239

Quarters > 2 > income Statement > total Other Income Expense Net

2750000

Quarters > 2 > balance Sheet > cash

216948000

Quarters > 2 > balance Sheet > short Term Investments

-

Quarters > 2 > balance Sheet > receivables

14572000

Quarters > 2 > balance Sheet > inventories

-

Quarters > 2 > balance Sheet > total Current Assets

278794000

Quarters > 2 > balance Sheet > property Plant Equipment

34606000

Quarters > 2 > balance Sheet > total Assets

331785000

Quarters > 2 > balance Sheet > payables

6179000

Quarters > 2 > balance Sheet > short Term Debt

3671000

Quarters > 2 > balance Sheet > long Term Debt

15000000

Quarters > 2 > balance Sheet > total Liabilities

98026000

Quarters > 2 > balance Sheet > equity

233759000

Quarters > 2 > cash Flow > net Income

-14076000

Quarters > 2 > cash Flow > depreciation

801000

Quarters > 2 > cash Flow > change In Working Capital

-28546000

Quarters > 2 > cash Flow > cash From Operations

-35138000

Quarters > 2 > cash Flow > capital Expenditures

137000

Quarters > 2 > cash Flow > cash From Investing

-137000

Quarters > 2 > cash Flow > cash From Financing

15195000

Quarters > 2 > cash Flow > net Change In Cash

-20080000

Quarters > 2 > ratios > PE

-0.519275463902313

Quarters > 2 > ratios > PB

0.8894232521528583

Quarters > 2 > ratios > ROE

-6.0215863346438

Quarters > 2 > ratios > ROA

-4.242506442425064

Quarters > 2 > ratios > FCF

-35275000

Quarters > 2 > ratios > Piotroski FScore

0

Quarters > 2 > ratios > fcf Percent

-1.2005649717514124

Quarters > 2 > health Score

33

Quarters > 3 > quarter

2024-12-31

Quarters > 3 > income Statement > revenue

21000000

Quarters > 3 > income Statement > cost Of Revenue

819000

Quarters > 3 > income Statement > gross Profit

21000000

Quarters > 3 > income Statement > operating Expenses

54394000

Quarters > 3 > income Statement > operating Income

-33394000

Quarters > 3 > income Statement > interest Expense

0

Quarters > 3 > income Statement > pretax Income

-30009000

Quarters > 3 > income Statement > net Income

-30005000

Quarters > 3 > income Statement > eps

-1.1112962962962962

Quarters > 3 > income Statement > dividends Per Share

-

Quarters > 3 > income Statement > shares Outstanding

27000000

Quarters > 3 > income Statement > income Tax Expense

-4000

Quarters > 3 > income Statement > EBITDA

-29190000

Quarters > 3 > income Statement > operating Margin

-159.01904761904763

Quarters > 3 > income Statement > total Other Income Expense Net

3385000

Quarters > 3 > balance Sheet > cash

237028000

Quarters > 3 > balance Sheet > short Term Investments

-

Quarters > 3 > balance Sheet > receivables

3974000

Quarters > 3 > balance Sheet > inventories

-

Quarters > 3 > balance Sheet > total Current Assets

305979000

Quarters > 3 > balance Sheet > property Plant Equipment

36205000

Quarters > 3 > balance Sheet > total Assets

344069000

Quarters > 3 > balance Sheet > payables

7194000

Quarters > 3 > balance Sheet > short Term Debt

3552000

Quarters > 3 > balance Sheet > long Term Debt

-

Quarters > 3 > balance Sheet > total Liabilities

103091000

Quarters > 3 > balance Sheet > equity

240978000

Quarters > 3 > cash Flow > net Income

-30005000

Quarters > 3 > cash Flow > depreciation

819000

Quarters > 3 > cash Flow > change In Working Capital

20091000

Quarters > 3 > cash Flow > cash From Operations

-284000

Quarters > 3 > cash Flow > capital Expenditures

2449

Quarters > 3 > cash Flow > cash From Investing

-2447

Quarters > 3 > cash Flow > cash From Financing

134000

Quarters > 3 > cash Flow > net Change In Cash

-150000

Quarters > 3 > ratios > PE

-1.1112962962962962

Quarters > 3 > ratios > PB

0.8593730548016831

Quarters > 3 > ratios > ROE

-12.451344106100972

Quarters > 3 > ratios > ROA

-8.720634523889103

Quarters > 3 > ratios > FCF

-286449

Quarters > 3 > ratios > Piotroski FScore

1

Quarters > 3 > ratios > fcf Percent

-0.01364042857142857

Quarters > 3 > health Score

34

Valuation > metrics > PE

-0.49462998381638956

Valuation > metrics > PB

0.9286288236053776

Valuation > final Score

70

Valuation > verdict

7.1% Undervalued

Profitability > metrics > ROE

-5.988626597019047

Profitability > metrics > ROA

-5.396468699839486

Profitability > metrics > Net Margin

-0.7840942219112588

Profitability > final Score

0

Profitability > verdict

Weak

Risk > metrics > Debt Equity

0.25732212915091357

Risk > metrics > Interest Coverage

-21.64089121887287

Risk > final Score

-27

Risk > verdict

High

Liquidity > metrics > Current Ratio

45.38335458022218

Liquidity > metrics > Quick Ratio

45.38335458022218

Liquidity > final Score

100

Liquidity > verdict

Great

Prev Valuations > 0

70

Prev Valuations > 1

70

Prev Valuations > 2

70

Prev Profitabilities > 0

0

Prev Profitabilities > 1

0

Prev Profitabilities > 2

0

Prev Risks > 0

32

Prev Risks > 1

25

Prev Risks > 2

-103

Prev Liquidities > 0

100

Prev Liquidities > 1

100

Prev Liquidities > 2

100

Updated At

2025-12-12T13:55:52.471Z